山东威高集团医用高分子制品股份有限公司（威高股份，股票代码：01066）于2026年4月17日公告，再次在香港联交所回购股份。根据公告，回购股份数量为260,000股，占公司已发行股本的约0.0058%。本次回购价格区间为每股3.60港元至3.65港元，总耗资约94.26万港元。
本次回购完成后，公司已发行股本变为4,470,586,724股，库存股数量增至51,745,600股。同时，公司披露回购授权获得批准的日期为2025年5月27日，授权可回购股份总数为451,560,392股。截至目前，公司已在香港联交所及其他交易所合计回购45,097,200股，约占授权总数的9.987%。
公司在公告中确认，本次回购已遵守所有适用的上市规则及相关法律程序。公告由公司秘书黄妙玲签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.